Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Standard Therapy

Mixed Results for New Tx in Adrenal Cancer

Patients with advanced adrenocortical carcinoma lived no longer when standard therapy was combined with three-agent chemotherapy, but had a significantly higher response rate and progression-free survival (PFS), results of a large multicenter study showed.

Overall survival improved by almost 3 months with etoposide-doxorubicin-cisplatin (EDP) chemotherapy plus mitotane when compared with mitotane plus streptozocin, but… Mixed Results for New Tx in Adrenal Cancer   



bladder control problems1 - reflux1 - protein2 - sexually transmitted infections1 - three-agent chemotherapy1 - permanent kidney damage1 - bladder infection2 - enzalutamide1 - metastatic1 - diagnosis of prostate cancer1 - kidney pelvis1 - kidney stones16 - xgeva1 - advanced stage1 - male potency1 - robotic-assisted operations1 - mortality1 - cloaca1 - prostate specific antigen6 - infertility2 - prostatitis2 - renal pain1 - prostate cancers1 - bladder discomfort1 - dry mouth1 - hormonal treatment1 - oligospermia1 - risk factors1 - conners parent rating scale-revised1 - sexual outcome1 -